Growth-Regulated Oncogene Is Pivotal in Thrombin-Induced Angiogenesis
Authors:
Open Access
- 15 April 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (8) , 4125-4132
Abstract
The mechanism of thrombin-induced angiogenesis is poorly understood. Using a gene chip array to investigate the pro-malignant phenotype of thrombin-stimulated cells, we observed that thrombin markedly up-regulates growth-regulated oncogene-α (GRO-α) in several tumor cell lines as well as endothelial cells by mRNA and protein analysis. Thrombin enhanced the secretion of GRO-α from tumor cells 25- to 64-fold. GRO-α is a CXC chemokine with tumor-associated angiogenic as well as oncogenic activation following ligation of its CXCR2 receptor. GRO-α enhanced angiogenesis in the chick chorioallantoic membrane assay 2.2-fold, providing direct evidence for GRO-α as an angiogenic growth factor. Anti-GRO-α antibody completely inhibited the 2.7-fold thrombin-induced up-regulation of angiogenesis, as well as the 1.5-fold thrombin-induced up-regulation of both endothelial cell cord formation in Matrigel and growth in vitro. Thrombin as well as its PAR-1 receptor activation peptide [thrombin receptor activation peptide (TRAP)] as well as GRO-α all markedly increased vascular regulatory proteins and growth factors: matrix metalloproteinase (MMP)-1, MMP-2, vascular endothelial growth factor (VEGF), angiopoietin-2 (Ang-2), CD31, and receptors KDR and CXCR2 in human umbilical vein endothelial cells. All of the thrombin/TRAP gene up-regulations were completely inhibited by anti-GRO-α antibody and unaffected by irrelevant antibody. Similar inhibition of gene up-regulation as well as thrombin-induced chemotaxis was noted with small interfering RNA (shRNA) GRO-α KD 4T1 breast tumor and B16F10 melanoma cells. In vivo tumor growth studies in wild-type mice with shRNA GRO-α KD cells revealed 2- to 4-fold impaired tumor growth, metastasis, and angiogenesis, which was not affected by endogenous thrombin. Thus, thrombin-induced angiogenesis requires the up-regulation of GRO-α. Thrombin up-regulation of GRO-α in tumor cells as well as endothelial cells contributes to tumor angiogenesis. (Cancer Res 2006; 66(8): 4125-32)Keywords
This publication has 32 references indexed in Scilit:
- CXC chemokines in angiogenesisCytokine & Growth Factor Reviews, 2005
- Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasisBlood, 2004
- Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasisBlood, 2004
- Induction of KDR expression in bovine arterial endothelial cells by thrombin: Involvement of nitric oxideJournal of Cellular Physiology, 2002
- Expression of proangiogenic chemokine Gro 1 in low and high metastatic variants of Pam murine squamous cell carcinoma is differentially regulated by IL-1?, EGF and TGF-?1 through NF-?B dependent and independent mechanismsInternational Journal of Cancer, 2001
- Thrombin Receptor-Mediated Increase of Two Matrix Metalloproteinases, MMP-1 and MMP-3, in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylationBritish Journal of Haematology, 1996
- Thrombin increases the metastatic potential of tumor cellsInternational Journal of Cancer, 1993
- Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrixInternational Journal of Cancer, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989